385 related articles for article (PubMed ID: 33347592)
1. Significance of PR3-ANCA positivity in eosinophilic granulomatosis with polyangiitis (Churg-Strauss).
Papo M; Sinico RA; Teixeira V; Venhoff N; Urban ML; Iudici M; Mahrhold J; Locatelli F; Cassone G; Schiavon F; Seeliger B; Neumann T; Kroegel C; Groh M; Marvisi C; Samson M; Barba T; Jayne D; Troilo A; Thiel J; Hellmich B; Monti S; Montecucco C; Salvarani C; Kahn JE; Bonnotte B; Durel CA; Puéchal X; Mouthon L; Guillevin L; Emmi G; Vaglio A; Terrier B;
Rheumatology (Oxford); 2021 Sep; 60(9):4355-4360. PubMed ID: 33347592
[TBL] [Abstract][Full Text] [Related]
2. Clinical and prognostic features of Korean patients with MPO-ANCA, PR3-ANCA and ANCA-negative vasculitis.
Yoo J; Kim HJ; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
Clin Exp Rheumatol; 2017; 35 Suppl 103(1):111-118. PubMed ID: 28339364
[TBL] [Abstract][Full Text] [Related]
3. Clinical impact of proteinase 3-antineutrophil cytoplasmic antibody positivity in eosinophilic granulomatosis with polyangiitis.
Ahn SS; Song JJ; Park YB; Lee SW
Korean J Intern Med; 2022 Nov; 37(6):1241-1249. PubMed ID: 34883552
[TBL] [Abstract][Full Text] [Related]
4. Clinical Significance of MPO-ANCA in Eosinophilic Granulomatosis With Polyangiitis: Experience From a Longitudinal Chinese Cohort.
Liu S; Han L; Liu Y; Yang J; Zhang Y; Li M; Tian X; Zeng X; Wang L; Zhang F
Front Immunol; 2022; 13():885198. PubMed ID: 35833130
[TBL] [Abstract][Full Text] [Related]
5. Five factor score of more than 1 is associated with relapse during the first 2 year-follow up in patients with eosinophilic granulomatosis with polyangiitis.
Kim DS; Song JJ; Park YB; Lee SW
Int J Rheum Dis; 2017 Sep; 20(9):1261-1268. PubMed ID: 28261989
[TBL] [Abstract][Full Text] [Related]
6. Differential clinicopathologic features of EGPA-associated neuropathy with and without ANCA.
Nishi R; Koike H; Ohyama K; Fukami Y; Ikeda S; Kawagashira Y; Iijima M; Katsuno M; Sobue G
Neurology; 2020 Apr; 94(16):e1726-e1737. PubMed ID: 32217776
[TBL] [Abstract][Full Text] [Related]
7. Anti-Neutrophil Cytoplasmic Antibodies Positivity and Anti-Leukotrienes in Eosinophilic Granulomatosis with Polyangiitis: A Retrospective Monocentric Study on 134 Italian Patients.
Schroeder JW; Folci M; Losappio LM; Chevallard M; Sinico RA; Mirone C; De Luca F; Nichelatti M; Pastorello EA
Int Arch Allergy Immunol; 2019; 180(1):64-71. PubMed ID: 31189169
[TBL] [Abstract][Full Text] [Related]
8. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort.
Comarmond C; Pagnoux C; Khellaf M; Cordier JF; Hamidou M; Viallard JF; Maurier F; Jouneau S; Bienvenu B; Puéchal X; Aumaître O; Le Guenno G; Le Quellec A; Cevallos R; Fain O; Godeau B; Seror R; Dunogué B; Mahr A; Guilpain P; Cohen P; Aouba A; Mouthon L; Guillevin L;
Arthritis Rheum; 2013 Jan; 65(1):270-81. PubMed ID: 23044708
[TBL] [Abstract][Full Text] [Related]
9. Relationship among antineutrophil cytoplasmic antibody, blood urea nitrogen and complement in patients with eosinophilic granulomatosis polyangiitis (Churg-Strauss syndrome).
Kawakami T; Kimura S; Takeuchi S; Soma Y
J Dermatol; 2013 Jul; 40(7):511-5. PubMed ID: 23594281
[TBL] [Abstract][Full Text] [Related]
10. Seasonal Influence on Development of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Retrospective Cohort Study Conducted at Multiple Institutions in Japan (J-CANVAS).
Yoshida Y; Nakamoto N; Oka N; Kidoguchi G; Hosokawa Y; Araki K; Ishitoku M; Watanabe H; Sugimoto T; Mokuda S; Kida T; Yajima N; Omura S; Nakagomi D; Abe Y; Kadoya M; Takizawa N; Nomura A; Kukida Y; Kondo N; Yamano Y; Yanagida T; Endo K; Matsui K; Takeuchi T; Ichinose K; Kato M; Yanai R; Matsuo Y; Shimojima Y; Nishioka R; Okazaki R; Takata T; Ito T; Moriyama M; Takatani A; Miyawaki Y; Ito-Ihara T; Kawaguchi T; Kawahito Y; Hirata S
J Rheumatol; 2023 Sep; 50(9):1152-1158. PubMed ID: 37263656
[TBL] [Abstract][Full Text] [Related]
11. The Epidemiology of Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis in Olmsted County, Minnesota: A Twenty-Year US Population-Based Study.
Berti A; Cornec D; Crowson CS; Specks U; Matteson EL
Arthritis Rheumatol; 2017 Dec; 69(12):2338-2350. PubMed ID: 28881446
[TBL] [Abstract][Full Text] [Related]
12. Antineutrophil Cytoplasmic Antibodies and Organ-Specific Manifestations in Eosinophilic Granulomatosis with Polyangiitis: A Systematic Review and Meta-Analysis.
Chang HC; Chou PC; Lai CY; Tsai HH
J Allergy Clin Immunol Pract; 2021 Jan; 9(1):445-452.e6. PubMed ID: 32771687
[TBL] [Abstract][Full Text] [Related]
13. Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive Granulomatosis With Polyangiitis (Wegener's) Is a Clinically Distinct Subset of ANCA-Associated Vasculitis: A Retrospective Analysis of 315 Patients From a German Vasculitis Referral Center.
Schirmer JH; Wright MN; Herrmann K; Laudien M; Nölle B; Reinhold-Keller E; Bremer JP; Moosig F; Holle JU
Arthritis Rheumatol; 2016 Dec; 68(12):2953-2963. PubMed ID: 27333332
[TBL] [Abstract][Full Text] [Related]
14. Revisiting the systemic vasculitis in eosinophilic granulomatosis with polyangiitis (Churg-Strauss): A study of 157 patients by the Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires and the European Respiratory Society Taskforce on eosinophilic granulomatosis with polyangiitis (Churg-Strauss).
Cottin V; Bel E; Bottero P; Dalhoff K; Humbert M; Lazor R; Sinico RA; Sivasothy P; Wechsler ME; Groh M; Marchand-Adam S; Khouatra C; Wallaert B; Taillé C; Delaval P; Cadranel J; Bonniaud P; Prévot G; Hirschi S; Gondouin A; Dunogué B; Chatté G; Briault C; Pagnoux C; Jayne D; Guillevin L; Cordier JF;
Autoimmun Rev; 2017 Jan; 16(1):1-9. PubMed ID: 27671089
[TBL] [Abstract][Full Text] [Related]
15. Spectrum of ANCA-specificities in eosinophilic granulomatosis with polyangiitis. A retrospective multicentre study.
Arnold S; Mahrhold J; Kerstein-Staehle A; Riemekasten G; Csernok E; Hellmich B; Venhoff N; Thiel J; Affeldt K; Jahnke A; Lamprecht P
Clin Exp Rheumatol; 2023 Apr; 41(4):936-942. PubMed ID: 37073637
[TBL] [Abstract][Full Text] [Related]
16. Clinical Characteristics of EGPA Patients in Comparison to GPA Subgroup with Increased Blood Eosinophilia from POLVAS Registry.
Drynda A; Padjas A; Wójcik K; Dziedzic R; Biedroń G; Wawrzycka-Adamczyk K; Włudarczyk A; Wilańska J; Musiał J; Zdrojewski Z; Czuszyńska Z; Masiak A; Majdan M; Jeleniewicz R; Augustyniak-Bartosik H; Jakuszko K; Krajewska M; Dębska-Ślizień A; Storoniak H; Bułło-Piontecka B; Tłustochowicz W; Kur-Zalewska J; Wisłowska M; Głuszko P; Madej M; Jassem E; Damps-Konstańska I; Kucharz E; Brzosko M; Milchert M; Hawrot-Kawecka A; Miłkowska-Dymanowska J; Górski P; Lewandowska-Polak A; Makowska J; Zalewska J; Zaręba L; Bazan-Socha S
J Immunol Res; 2024; 2024():4283928. PubMed ID: 38699219
[TBL] [Abstract][Full Text] [Related]
17. Neutrophil extracellular traps formation in patients with eosinophilic granulomatosis with polyangiitis: association with eosinophilic inflammation.
Natorska J; Ząbczyk M; Siudut J; Krawiec P; Mastalerz L; Undas A
Clin Exp Rheumatol; 2017; 35 Suppl 103(1):27-32. PubMed ID: 28229830
[TBL] [Abstract][Full Text] [Related]
18. Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive and ANCA-Negative Patients With Granulomatosis With Polyangiitis (Wegener's): Distinct Patient Subsets.
Miloslavsky EM; Lu N; Unizony S; Choi HK; Merkel PA; Seo P; Spiera R; Langford CA; Hoffman GS; Kallenberg CG; St Clair EW; Tchao NK; Fervenza F; Monach PA; Specks U; Stone JH
Arthritis Rheumatol; 2016 Dec; 68(12):2945-2952. PubMed ID: 27428559
[TBL] [Abstract][Full Text] [Related]
19. Genetics of ANCA-associated vasculitis: role in pathogenesis, classification and management.
Trivioli G; Marquez A; Martorana D; Tesi M; Kronbichler A; Lyons PA; Vaglio A
Nat Rev Rheumatol; 2022 Oct; 18(10):559-574. PubMed ID: 36109667
[TBL] [Abstract][Full Text] [Related]
20. Comparative study of granulomatosis with polyangiitis subsets according to ANCA status: data from the French Vasculitis Study Group Registry.
Puéchal X; Iudici M; Pagnoux C; Cohen P; Hamidou M; Aouba A; Lifermann F; Ruivard M; Aumaître O; Bonnotte B; Maurier F; Le Gallou T; Hachulla E; Karras A; Khouatra C; Jourde-Chiche N; Viallard JF; Blanchard-Delaunay C; Godmer P; Le Quellec A; Quéméneur T; de Moreuil C; Mouthon L; Terrier B; Guillevin L;
RMD Open; 2022 Mar; 8(1):. PubMed ID: 35296533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]